Clarametyx Biosciences Expands Scientific Advisory Board

Four new experts join the company's advisory panel to advance pipeline programs.

Jan. 27, 2026 at 11:55am

Got story updates? Submit your updates here. ›

Clarametyx Biosciences, a biotech company based in Columbus, Ohio, has appointed four new experts to its Scientific Advisory Board (SAB) - Bruce Forrest, MD, George Siber, MD, Obadiah Plante, PhD, and C. David Zarley, PhD. The new SAB members will provide guidance and expertise to help advance the company's pipeline of drug candidates.

Why it matters

Clarametyx is a promising biotech startup focused on developing novel therapies. Strengthening its scientific advisory board with experienced industry experts is a positive sign that the company is well-positioned to progress its research and development efforts.

The details

The four new SAB members bring a wealth of experience in areas such as vaccine development, immunology, and drug discovery. Their expertise will be invaluable as Clarametyx works to advance its pipeline of drug candidates targeting various diseases.

  • Clarametyx announced the new SAB appointments on January 27, 2026.

The players

Clarametyx Biosciences

A biotech company based in Columbus, Ohio that is developing novel therapies.

Bruce Forrest, MD

An expert in vaccine development who has joined Clarametyx's Scientific Advisory Board.

George Siber, MD

An immunology expert who has joined Clarametyx's Scientific Advisory Board.

Obadiah Plante, PhD

A drug discovery expert who has joined Clarametyx's Scientific Advisory Board.

C. David Zarley, PhD

An expert in various scientific disciplines who has joined Clarametyx's Scientific Advisory Board.

Got photos? Submit your photos here. ›

The takeaway

Clarametyx's expansion of its Scientific Advisory Board with experienced industry experts signals the company's commitment to advancing its pipeline of novel therapies and positioning itself for future success in the competitive biotech landscape.